Meng Hong

747 total citations
28 papers, 609 citations indexed

About

Meng Hong is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Meng Hong has authored 28 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Meng Hong's work include Protease and Inhibitor Mechanisms (7 papers), Immune Response and Inflammation (4 papers) and Bone health and treatments (3 papers). Meng Hong is often cited by papers focused on Protease and Inhibitor Mechanisms (7 papers), Immune Response and Inflammation (4 papers) and Bone health and treatments (3 papers). Meng Hong collaborates with scholars based in China, United States and Denmark. Meng Hong's co-authors include Sanaa Nabha, Wei Zhao, Meng Zhang, Lijuan Wang, Chengjiang Gao, Zhong Dong, Michael L. Cher, R. Daniel Bonfil, Aaron Sabbota and Kai Zhao and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Meng Hong

26 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng Hong China 11 285 214 188 186 62 28 609
Yanping Wang China 16 328 1.2× 183 0.9× 123 0.7× 192 1.0× 89 1.4× 32 656
Jun-Ting Cheng China 11 443 1.6× 210 1.0× 345 1.8× 270 1.5× 69 1.1× 15 852
Maria Shatz United States 12 397 1.4× 191 0.9× 304 1.6× 254 1.4× 69 1.1× 16 856
Cynthia L. Innes United States 16 585 2.1× 192 0.9× 255 1.4× 157 0.8× 38 0.6× 30 815
Jörg H. Leupold Germany 17 497 1.7× 394 1.8× 187 1.0× 119 0.6× 55 0.9× 26 818
Chiara Massa Germany 16 325 1.1× 141 0.7× 291 1.5× 379 2.0× 72 1.2× 42 733
Romi Gupta United States 19 650 2.3× 185 0.9× 215 1.1× 134 0.7× 87 1.4× 50 945
Jana Dobrovolná Czechia 13 493 1.7× 109 0.5× 178 0.9× 189 1.0× 35 0.6× 16 780
Uta Schaefer Germany 8 513 1.8× 162 0.8× 201 1.1× 360 1.9× 27 0.4× 8 773
Jia You China 15 332 1.2× 227 1.1× 84 0.4× 120 0.6× 53 0.9× 32 620

Countries citing papers authored by Meng Hong

Since Specialization
Citations

This map shows the geographic impact of Meng Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Hong more than expected).

Fields of papers citing papers by Meng Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Hong. The network helps show where Meng Hong may publish in the future.

Co-authorship network of co-authors of Meng Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Hong. A scholar is included among the top collaborators of Meng Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Hong. Meng Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hong, Meng, et al.. (2023). The transcription factor ATF2 promotes gastric cancer progression by activating the METTL3/cyclin D1 pathway. Drug Development Research. 84(6). 1325–1334. 10 indexed citations
2.
Cheng, Huiying, Can Huang, Xiang Gu, et al.. (2021). Bacterial Lipopolysaccharide Augmented Malignant Transformation and Promoted the Stemness in Prostate Cancer Epithelial Cells. Journal of Inflammation Research. Volume 14. 5849–5862. 6 indexed citations
3.
Zheng, Qiuxian, et al.. (2021). TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers. Biomedicine & Pharmacotherapy. 135. 111169–111169. 38 indexed citations
4.
Wang, Yunyun, Fengtian Wu, Chao Chen, et al.. (2021). Soluble urokinase plasminogen activator receptor is associated with short-term mortality and enhanced reactive oxygen species production in acute-on-chronic liver failure. BMC Gastroenterology. 21(1). 429–429. 4 indexed citations
5.
Liu, Shuo, et al.. (2021). Effect of Run Ze Tonic in Mice with Kidney-Yin Deficiency. Asian Journal of Beauty and Cosmetology. 19(1). 139–146. 1 indexed citations
6.
Jiang, Jiajia, et al.. (2020). Tumor Suppressive Maspin-Sensitized Prostate Cancer to Drug Treatment Through Negative Regulating Androgen Receptor Expression. Frontiers in Cell and Developmental Biology. 8. 573820–573820. 8 indexed citations
7.
Deng, Jingwen, Qin Yang, Xiaopeng Cai, et al.. (2020). Early use of dexamethasone increases Nr4a1 in Kupffer cells ameliorating acute liver failure in mice in a glucocorticoid receptor-dependent manner. Journal of Zhejiang University SCIENCE B. 21(9). 727–739. 9 indexed citations
8.
Deng, Jingwen, Meng Hong, Yanli Ren, et al.. (2019). Ethical considerations of cellular immunotherapy for cancer. Journal of Zhejiang University SCIENCE B. 20(1). 23–31. 12 indexed citations
9.
Hong, Meng, et al.. (2018). PD-1 Polymorphisms Are Associated with Susceptibility of Acute Anterior Uveitis in Chinese Population. DNA and Cell Biology. 38(2). 121–128. 6 indexed citations
10.
Hong, Meng, et al.. (2016). Association of Genotyping of Bacillus cereus with Clinical Features of Post-Traumatic Endophthalmitis. PLoS ONE. 11(2). e0147878–e0147878. 6 indexed citations
11.
Hong, Meng. (2013). Establishment and Evaluation of Mice Model with Kidney Yang Deficiency Infected by Influenza Virus. Zhongguo shiyan fangjixue zazhi. 3 indexed citations
12.
Zhang, Meng, Lijuan Wang, Xueying Zhao, et al.. (2012). TRAF-interacting protein (TRIP) negatively regulates IFN-β production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1. The Journal of Experimental Medicine. 209(10). 1703–1711. 113 indexed citations
13.
Li, Zhihui, Fengli Zhang, Yan Li, et al.. (2009). Initial evaluation of the biosafety of recombinant HBV preS2/S-AD5.. Journal of Shandong University. 47(5). 27–30. 3 indexed citations
14.
Dong, Zhong, Allen Saliganan, Meng Hong, et al.. (2008). Prostate Cancer Cell-Derived Urokinase-Type Plasminogen Activator Contributes to Intraosseous Tumor Growth and Bone Turnover. Neoplasia. 10(5). 439–449. 37 indexed citations
15.
Nabha, Sanaa, Hamilto Yamamoto, Zhong Dong, et al.. (2008). Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP‐12 dependent manner. International Journal of Cancer. 122(11). 2482–2490. 47 indexed citations
16.
Wiesner, Christoph, R. Daniel Bonfil, Zhong Dong, et al.. (2007). Heterogeneous Activation of MMP-9 Due to Prostate Cancer-Bone Interaction. Urology. 69(4). 795–799. 15 indexed citations
17.
Qu, Xian‐Jun, Yunxia Yuan, Wenfang Xu, et al.. (2006). Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.. PubMed. 26(5A). 3573–8. 22 indexed citations
18.
Nabha, Sanaa, Selina Glaros, Meng Hong, et al.. (2005). Upregulation of PKC-δ contributes to antiestrogen resistance in mammary tumor cells. Oncogene. 24(19). 3166–3176. 68 indexed citations
19.
Bonfil, R. Daniel, Aaron Sabbota, Sanaa Nabha, et al.. (2005). Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism‐based selective gelatinase inhibitor. International Journal of Cancer. 118(11). 2721–2726. 80 indexed citations
20.
Yoo, George H., Marie P. Piechocki, Fulvio Lonardo, et al.. (2002). In Vivo Characteristics of HPV‐Immortalized and Carcinogen Transformed Oral Keratinocytes. The Laryngoscope. 112(9). 1672–1679. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026